provides access to compounded medications for qualified patients. Compounded medications are not FDA-approved and may differ in risks, benefits, and side effects from FDA-approved products. Individual results may vary. Novo Nordisk Inc. and Eli Lilly and Company are the only U.S. manufacturers of FDA-approved semaglutide (Rybelsus®, Ozempic®, Wegovy®) and tirzepatide (Zepbound®, Mounjaro®), respectively. They do not sell these medications for compounding.
